RVTY — REVVITY, INC.
—
NYSE ·
Unknown ·
Unknown ·
CIK 31791 ·
Last close
$100.55
Market Cap
$11.22B
52W High
$106.21
52W Low
$81.22
ADV30
1,548,114
Next earnings
2026-07-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 772,056,000 | 421,659,000 | 111,749,000 | 98,364,000 | 12,168,411,000 | 919,860,000 | 4,918,051,000 |
| Sep 2025 | 698,949,000 | 374,604,000 | 81,896,000 | 46,652,000 | 12,138,952,000 | 931,386,000 | 4,763,056,000 |
| Jun 2025 | 720,284,000 | 392,556,000 | 89,065,000 | 53,948,000 | 12,362,789,000 | 991,849,000 | 4,806,621,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$580,746,000
Investing CF
$-136,122,000
Financing CF
$-782,754,000
CapEx
$-77,315,000
Dividends Paid
$-32,207,000
Buybacks
$-753,717,000
EPS Diluted TTM
$2.09
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$6,087,222,000
Inventory
$387,505,000
Receivables
$691,380,000
ST Investments
$0
EBIT TTM
$359,826,000
Pretax Income TTM
$265,887,000
Interest Exp TTM
$93,939,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,902,406,912
EBITDA
$855,235,008
Free Cash Flow
$508,969,248
Enterprise Value
$13,707,194,368
Total Cash
$860,320,000
Total Debt
$3,350,179,072
Shares Out
111,559,773
Trailing EPS
$2.08
Book Value
$64.34
ROE
3.2%
ROA
2.3%
Div Yield
0.28%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,856,051,000 | 356,635,000 | 241,201,000 | 12,168,411,000 | 4,918,051,000 | — | 582,933,000 |
| Dec 2024 | 2,755,026,000 | 346,741,000 | 270,385,000 | 12,392,478,000 | 4,725,604,000 | — | 628,299,000 |
| Dec 2023 | 2,750,571,000 | 300,562,000 | 693,094,000 | 13,564,665,000 | 5,691,926,000 | — | 91,272,000 |
| Dec 2022 | 3,311,822,000 | 742,699,000 | 569,179,000 | 14,129,855,000 | 6,746,979,000 | — | 679,810,000 |
TTM Snapshot
Revenues TTM
$2,927,907,000
NetIncome TTM
$316,949,000
OpCashFlow TTM
$0
Assets (Latest)
$12,392,478,000
Forward EPS
$5.82
Max Pain — expiry 2026-09-18
max pain strike: $100.00 · spot: $101.22 · call oi: 759 · put oi: 293
Expected Move to 2026-09-18:
±$17.70
(17.49%) —
implied range
$83.52 –
$118.92
· ATM straddle on $100.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CHLSY | Chocoladefabriken Lindt & Spruengli AG/ADR | $11.10B | $11.41 | — |
| OBIIF | OBIC Co., Ltd./ADR | $11.04B | $25.61 | — |
| CGNX | COGNEX CORP | $10.97B | $65.90 | — |
| ONON | On Holding AG | $11.64B | $38.69 | — |
| TRMB | TRIMBLE INC. | $11.70B | $50.21 | — |
News headlines (Yahoo Finance, 1h cache)
2 Profitable Stocks with Impressive Fundamentals and 1 We Turn Down
2026-06-15 12:36 · Yahoo
Revvity (RVTY) Valuation Check After China Immunodiagnostics Exit Plan And Solid First Quarter Results
2026-06-08 21:17 · Yahoo
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?
2026-06-04 15:30 · Yahoo
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers
2026-06-01 16:08 · Yahoo
Is Danaher Stock Underperforming the S&P 500?
2026-05-29 14:28 · Yahoo
Revvity Stock: Analyst Estimates & Ratings
2026-05-22 14:00 · Yahoo
Revvity's (NYSE:RVTY) Conservative Accounting Might Explain Soft Earnings
2026-05-20 10:21 · Yahoo
The Top 5 Analyst Questions From Revvity’s Q1 Earnings Call
2026-05-15 11:16 · Yahoo
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay
2026-05-14 15:59 · Yahoo
Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution
2026-05-13 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.